1. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Science China Life sciences. 2020;63(3):364-74. [
DOI:10.1007/s11427-020-1643-8] [
PMID] [
PMCID]
2. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell host & microbe. 2020;27(3):325-8.
https://doi.org/10.1016/j.chom.2021.02.016 [
DOI:10.1016/j.chom.2020.02.001] [
PMID]
3. Graham RL, Baric RS. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. Journal of virology. 2010;84(7):3134-46. [
DOI:10.1128/JVI.01394-09] [
PMID] [
PMCID]
4. Worldometer. COVID-19 coronavirus pandemic. 2021 [Available from: https://www.worldometers.info/coronavirus/.
5. Musa S, Dergaa I, Mansy O. The puzzle of Autism in the time of COVID 19 pandemic:"Light it up Blue". Psychology and Education Journal. 2021;58(5):1861-73.
6. Varma A, Dergaa I, Mohammed AR, Abubaker M, Al Naama A, Mohammed S, et al. Covid-19 and diabetes in primary care - How do hematological parameters present in this cohort? Expert review of endocrinology & metabolism. 2021;16(3):147-53. [
DOI:10.1080/17446651.2021.1909472] [
PMID]
7. Trabelsi K, Ammar A, Masmoudi L, Boukhris O, Chtourou H, Bouaziz B, et al. Globally altered sleep patterns and physical activity levels by confinement in 5056 individuals: ECLB COVID-19 international online survey. Biology of Sport. 2021;38(4):495-506.
8. Trabelsi K, Ammar A, Masmoudi L, Boukhris O, Chtourou H, Bouaziz B, et al. Sleep Quality and Physical Activity as Predictors of Mental Wellbeing Variance in Older Adults during COVID-19 Lockdown: ECLB COVID-19 International Online Survey. International journal of environmental research and public health. 2021;18(8).
9. Sharma O, Sultan AA, Ding H, Triggle CR. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19. Frontiers in immunology. 2020;11:585354. [
DOI:10.3389/fimmu.2020.585354] [
PMID] [
PMCID]
10. Varma A, Dergaa I, Ashkanani M, Musa S, Zidan M. Analysis of Qatar's successful public health policy in dealing with the Covid-19 pandemic. International Journal of Medical Reviews and Case Reports. 2021;5(2):6-11.. [
DOI:10.5455/IJMRCR.covid-19-qatar]
11. Varma A, Dergaa I, Zidan M, Chaabane M. Covid-19:"Drive thru swabbing hubs"-safe and effective testing for travellers. The Journal of Medical Research. 2020;6(6):311-2. [
DOI:10.31254/jmr.2020.6613]
12. Varma A, Abubaker M, Dergaa I. Extensive Saliva based COVID-19 testing-the way forward to curtail the global pandemic. The Journal of Medical Research. 2020;6(6):309-10. [
DOI:10.31254/jmr.2020.6612]
13. Musa S, Al Baker W, Al Muraikhi H, Nazareno D, Al Naama A, Dergaa I. Wellness Program Within Primary Health Care: How to Avoid "No Show" to Planned Appointments?-A Patient-Centred Care Perspective. Physical Activity and Health. 2021;5(1). [
DOI:10.5334/paah.90]
14. Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, et al. Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection. Clinical microbiology reviews. 2021;34(3). [
DOI:10.1128/CMR.00228-20] [
PMID] [
PMCID]
15. Fiore JR, Centra M, De Carlo A, Granato T, Rosa A, Sarno M, et al. Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2. Journal of Medical Virology. 2021;93(3):1739-42. [
DOI:10.1002/jmv.26425] [
PMID] [
PMCID]
16. World Health Organization. Coronavirus disease (COVID-19): Herd immunity, lockdowns and COVID-19 2020 [Available from: https://www.who.int/news-room/q-a-detail/herd-immunity-lockdowns-and-covid-19.
17. Randolph HE, Barreiro LB. Herd Immunity: Understanding COVID-19. Immunity. 2020;52(5):737-41. [
DOI:10.1016/j.immuni.2020.04.012] [
PMID] [
PMCID]
18. Our World in Data. Coronavirus (COVID-19) Vaccinations [Available from: https://ourworldindata.org/covid-vaccinations
19. Tanne JH. Covid-19: FDA panel votes to authorise Pfizer BioNTech vaccine. BMJ. 2020;371:m4799. [
DOI:10.1136/bmj.m4799] [
PMID]
20. Mishra SK, Tripathi T. One year update on the COVID-19 pandemic: Where are we now? Acta tropica. 2021;214:105778. [
DOI:10.1016/j.actatropica.2020.105778] [
PMID] [
PMCID]
21. Chung YH, Beiss V, Fiering SN, Steinmetz NF. COVID-19 Vaccine Frontrunners and Their Nanotechnology Design. ACS Nano. 2020;14(10):12522-37. [
DOI:10.1021/acsnano.0c07197] [
PMID] [
PMCID]
22. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic. 2021 [Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use.
23. Kronbichler A, Kresse D, Yoon S, Lee KH, Effenberger M, Shin JI. Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;98:180-6. [
DOI:10.1016/j.ijid.2020.06.052] [
PMID] [
PMCID]
24. Deeks J, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S, et al. Antibody tests for identification of current and past infection with SARS‐CoV‐2. Cochrane Database of Systematic Reviews. 2020;6(6). [
DOI:10.1002/14651858.CD013652] [
PMID] [
PMCID]
25. Seow J, Graham C, Merrick B, Acors S, Pickering S, Steel KJA, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nature Microbiology. 2020;5(12):1598-607. [
DOI:10.1038/s41564-020-00813-8] [
PMID] [
PMCID]
26. Ward H, Cooke G, Atchison C, Whitaker M, Elliott J, Moshe M, et al. Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults. medRxiv. 2020:2020.10.26.20219725. [
DOI:10.1101/2020.10.26.20219725]
27. Sun Y, Ho M. Emerging antibody-based therapeutics against SARS-CoV-2 during the global pandemic. Antibody Therapeutics. 2020;3(4):246-56. [
DOI:10.1093/abt/tbaa025] [
PMID] [
PMCID]
28. Dawood AA. Mutated COVID-19 may foretell a great risk for mankind in the future. New Microbes and New Infections. 2020;35:100673. [
DOI:10.1016/j.nmni.2020.100673] [
PMID] [
PMCID]
29. Sevajol M, Subissi L, Decroly E, Canard B, Imbert I. Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus. Virus research. 2014;194:90-9. [
DOI:10.1016/j.virusres.2014.10.008] [
PMID] [
PMCID]
30. Smith EC, Blanc H, Surdel MC, Vignuzzi M, Denison MR. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics. PLoS pathogens. 2013;9(8):e1003565. [
DOI:10.1371/journal.ppat.1003565] [
PMID] [
PMCID]
31. Fauver JR, Petrone ME, Hodcroft EB, Shioda K, Ehrlich HY, Watts AG, et al. Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States. Cell. 2020;181(5):990-6.e5. [
DOI:10.1016/j.cell.2020.04.021] [
PMID] [
PMCID]
32. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell host & microbe. 2020;27(3):325-8.
https://doi.org/10.1016/j.chom.2021.02.016 [
DOI:10.1016/j.chom.2020.02.001] [
PMID]
33. Boni MF, Gog JR, Andreasen V, Feldman MW. Epidemic dynamics and antigenic evolution in a single season of influenza A. Proceedings of the Royal Society B: Biological Sciences. 2006;273(1592):1307-16. [
DOI:10.1098/rspb.2006.3466] [
PMID] [
PMCID]
34. Sehra ST, Salciccioli JD, Wiebe DJ, Fundin S, Baker JF. Maximum Daily Temperature, Precipitation, Ultraviolet Light, and Rates of Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in the United States. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020;71(9):2482-7. [
DOI:10.1093/cid/ciaa681] [
PMID] [
PMCID]
35. Ren L, Zhang Y, Li J, Xiao Y, Zhang J, Wang Y, et al. Genetic drift of human coronavirus OC43 spike gene during adaptive evolution. Scientific Reports. 2015;5(1):11451. [
DOI:10.1038/srep11451] [
PMID] [
PMCID]
36. Vijgen L, Keyaerts E, Lemey P, Moës E, Li S, Vandamme AM, et al. Circulation of genetically distinct contemporary human coronavirus OC43 strains. Virology. 2005;337(1):85-92. [
DOI:10.1016/j.virol.2005.04.010] [
PMID] [
PMCID]
37. Chibo D, Birch C. Analysis of human coronavirus 229E spike and nucleoprotein genes demonstrates genetic drift between chronologically distinct strains. The Journal of general virology. 2006;87(Pt 5):1203-8. [
DOI:10.1099/vir.0.81662-0] [
PMID]
38. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science (New York, NY). 2003;302(5643):276-8. [
DOI:10.1126/science.1087139] [
PMID]
39. Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC, et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(7):2430-5. [
DOI:10.1073/pnas.0409608102] [
PMID] [
PMCID]
40. Sui J, Aird DR, Tamin A, Murakami A, Yan M, Yammanuru A, et al. Broadening of Neutralization Activity to Directly Block a Dominant Antibody-Driven SARS-Coronavirus Evolution Pathway. PLoS pathogens. 2008;4(11):e1000197. [
DOI:10.1371/journal.ppat.1000197] [
PMID] [
PMCID]
41. BBC News. 'New variant' of coronavirus identified in England 2020 [Available from: https://www.bbc.com/news/health-55308211.
42. Pharmaceutical Technology. Coronavirus: A timeline of how the deadly COVID-19 outbreak is evolving 2021 [Available from: https://www.pharmaceutical-technology.com/news/coronavirus-a-timeline-of-how-the-deadly-outbreak-evolved/.
43. Yang R, Kraft Colleen S. Plague: Recognition, Treatment, and Prevention. Journal of Clinical Microbiology.56(1):e01519-17. [
DOI:10.1128/JCM.01519-17]
44. Butcher GA, Mitchell GH. The role of Plasmodium knowlesi in the history of malaria research. Parasitology. 2018;145(1):6-17. [
DOI:10.1017/S0031182016001888] [
PMID]
45. Hennessey K, Schluter WW, Wang X, Boualam L, Jee Y, Mendoza-Aldana J, et al. Are we there yet? Assessing achievement of vaccine-preventable disease goals in WHO's Western Pacific Region. Vaccine. 2014;32(34):4259-66. [
DOI:10.1016/j.vaccine.2014.02.093] [
PMID]
46. Meyer H, Ehmann R, Smith GL. Smallpox in the Post-Eradication Era. Viruses. 2020;12(2). [
DOI:10.3390/v12020138] [
PMID] [
PMCID]
47. Sparrow AK, Brosseau LM, Harrison RJ, Osterholm MT. Protecting Olympic Participants from Covid-19 - The Urgent Need for a Risk-Management Approach. New England Journal of Medicine. 2021;385(1):e2. [
DOI:10.1056/NEJMp2108567] [
PMID]
48. Dergaa I, Varma A, Tabben M, Ali Malik R, Sheik S, Vedasalam S, et al. Organising football matches with spectators during the COVID-19 pandemic: What can we learn from the Amir Cup Football Final of Qatar 2020? A call for action. Biology of Sport. 2021;38(4):677-81. [
DOI:10.5114/biolsport.2021.103568]
49. McLarnon M, Heron N. The COVID-19 athlete passport: a tool for managing athlete COVID-19 status surrounding the Tokyo 2020 Olympic games. The Physician and Sportsmedicine. 2021:1-4. [
DOI:10.1080/00913847.2021.1885964] [
PMID]